Transforming growth factor betas and their receptors in human liver cirrhosis

Hans U. Baer, Helmut Friess, Mohamed Abou-Shady, Pascal Berberat, Arthur Zimmermann, Leslie I. Gold, Murray Korc, Markus W. Büchler

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Background. Transforming growth factor betas (TGF-βs) are a group of homologous polypeptides that exert pleiotropic effects on various cell types and stimulate the formation of extracellular matrix and fibrosis. To evaluate whether TGF-β isoforms (TGF-β1, TGF-β2 and TGF-β3) and their receptors (types I-III) are also of importance in the pathophysiology of liver cirrhosis, we analysed their concomitant expression and localization in human liver cirrhosis. Patients. Cirrhotic liver tissue samples were obtained from 17 patients (four women, 13 men) with a median age of 41 years (range 22-67). Normal liver tissues from ten patients (seven women, three men) with a median age of 55 years (range 45-75) served as controls. Methods. The tissues were fixed in Bouin's solution and paraffin-embedded for histological analysis. For RNA analysis, freshly obtained tissue samples were snap-frozen in liquid nitrogen and stored at -80°C until analysed. Northern blot analysis was used to examine the expression of TGF-β1, β2 and β3 and their receptors, type I (TβR-I), type II (TβR-II) and type III (TβR-III). Immunohistochemistry was performed to determine the localization of the corresponding proteins in the normal and the cirrhotic liver. Results. Northern blot analysis revealed enhanced expression (P <0.05) of TGF-β1 (twofold increase), TGF-β2 (threefold increase) and TGF-β3 (8.5-fold increase) and of TβR-II (threefold increase) mRNA in liver cirrhosis in comparison with normal controls. In contrast, TβR-I (ALK-5) and TβR-III mRNA expression showed no significant changes. No TGF-β isoform immunoreactivity was present in hepatocytes in either normal livers or in liver cirrhosis. However, in liver cirrhosis, intense TGF-β1 immunoreactivity was present in bile duct and ductular epithelial cells (including ductular proliferations) and in inflammatory cells. In a few sinusoidal lining cells, faint TGF-β1 and moderate TGF-β2 immunoreactivity was present. TGF-β3 immunostaining was present in bile duct and ductular epithelial cells, in inflammatory cells and in fibroblast-like spindle cells in liver cirrhosis. For TβR-I and TβR-II, the immunoreactivity was localized in hepatocytes and biliary cells in normal and cirrhotic liver tissues, with higher intensity for TβR-II in the cirrhotic liver. Conclusion. Enhanced expression of all three TGF-β isoforms and of TβR-II in liver cirrhosis suggests their involvement in this fibrotic disorder. The higher immunoreactivity of the three TGF-β isoforms in the bile duct epithelial cells in cirrhotic tissues suggests a possible role of these cells in the pathogenesis of liver cirrhosis.

Original languageEnglish (US)
Pages (from-to)1031-1039
Number of pages9
JournalEuropean Journal of Gastroenterology and Hepatology
Volume10
Issue number12
StatePublished - 1998
Externally publishedYes

Fingerprint

Transforming Growth Factor beta Receptors
Liver Cirrhosis
Liver
Protein Isoforms
Bile Ducts
Epithelial Cells
Northern Blotting
Hepatocytes
Messenger RNA
Transforming Growth Factor beta
Paraffin
Extracellular Matrix
Fibrosis
Nitrogen
Fibroblasts
Immunohistochemistry
RNA
Peptides

Keywords

  • Fibrogenesis
  • Immunohistochemistry
  • Liver cirrhosis
  • Northern blot analysis
  • Transforming growth factor-beta
  • Transforming growth factor-beta receptors

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Baer, H. U., Friess, H., Abou-Shady, M., Berberat, P., Zimmermann, A., Gold, L. I., ... Büchler, M. W. (1998). Transforming growth factor betas and their receptors in human liver cirrhosis. European Journal of Gastroenterology and Hepatology, 10(12), 1031-1039.

Transforming growth factor betas and their receptors in human liver cirrhosis. / Baer, Hans U.; Friess, Helmut; Abou-Shady, Mohamed; Berberat, Pascal; Zimmermann, Arthur; Gold, Leslie I.; Korc, Murray; Büchler, Markus W.

In: European Journal of Gastroenterology and Hepatology, Vol. 10, No. 12, 1998, p. 1031-1039.

Research output: Contribution to journalArticle

Baer, HU, Friess, H, Abou-Shady, M, Berberat, P, Zimmermann, A, Gold, LI, Korc, M & Büchler, MW 1998, 'Transforming growth factor betas and their receptors in human liver cirrhosis', European Journal of Gastroenterology and Hepatology, vol. 10, no. 12, pp. 1031-1039.
Baer HU, Friess H, Abou-Shady M, Berberat P, Zimmermann A, Gold LI et al. Transforming growth factor betas and their receptors in human liver cirrhosis. European Journal of Gastroenterology and Hepatology. 1998;10(12):1031-1039.
Baer, Hans U. ; Friess, Helmut ; Abou-Shady, Mohamed ; Berberat, Pascal ; Zimmermann, Arthur ; Gold, Leslie I. ; Korc, Murray ; Büchler, Markus W. / Transforming growth factor betas and their receptors in human liver cirrhosis. In: European Journal of Gastroenterology and Hepatology. 1998 ; Vol. 10, No. 12. pp. 1031-1039.
@article{ac59f2ce981e41c2b68a82de3b54850d,
title = "Transforming growth factor betas and their receptors in human liver cirrhosis",
abstract = "Background. Transforming growth factor betas (TGF-βs) are a group of homologous polypeptides that exert pleiotropic effects on various cell types and stimulate the formation of extracellular matrix and fibrosis. To evaluate whether TGF-β isoforms (TGF-β1, TGF-β2 and TGF-β3) and their receptors (types I-III) are also of importance in the pathophysiology of liver cirrhosis, we analysed their concomitant expression and localization in human liver cirrhosis. Patients. Cirrhotic liver tissue samples were obtained from 17 patients (four women, 13 men) with a median age of 41 years (range 22-67). Normal liver tissues from ten patients (seven women, three men) with a median age of 55 years (range 45-75) served as controls. Methods. The tissues were fixed in Bouin's solution and paraffin-embedded for histological analysis. For RNA analysis, freshly obtained tissue samples were snap-frozen in liquid nitrogen and stored at -80°C until analysed. Northern blot analysis was used to examine the expression of TGF-β1, β2 and β3 and their receptors, type I (TβR-I), type II (TβR-II) and type III (TβR-III). Immunohistochemistry was performed to determine the localization of the corresponding proteins in the normal and the cirrhotic liver. Results. Northern blot analysis revealed enhanced expression (P <0.05) of TGF-β1 (twofold increase), TGF-β2 (threefold increase) and TGF-β3 (8.5-fold increase) and of TβR-II (threefold increase) mRNA in liver cirrhosis in comparison with normal controls. In contrast, TβR-I (ALK-5) and TβR-III mRNA expression showed no significant changes. No TGF-β isoform immunoreactivity was present in hepatocytes in either normal livers or in liver cirrhosis. However, in liver cirrhosis, intense TGF-β1 immunoreactivity was present in bile duct and ductular epithelial cells (including ductular proliferations) and in inflammatory cells. In a few sinusoidal lining cells, faint TGF-β1 and moderate TGF-β2 immunoreactivity was present. TGF-β3 immunostaining was present in bile duct and ductular epithelial cells, in inflammatory cells and in fibroblast-like spindle cells in liver cirrhosis. For TβR-I and TβR-II, the immunoreactivity was localized in hepatocytes and biliary cells in normal and cirrhotic liver tissues, with higher intensity for TβR-II in the cirrhotic liver. Conclusion. Enhanced expression of all three TGF-β isoforms and of TβR-II in liver cirrhosis suggests their involvement in this fibrotic disorder. The higher immunoreactivity of the three TGF-β isoforms in the bile duct epithelial cells in cirrhotic tissues suggests a possible role of these cells in the pathogenesis of liver cirrhosis.",
keywords = "Fibrogenesis, Immunohistochemistry, Liver cirrhosis, Northern blot analysis, Transforming growth factor-beta, Transforming growth factor-beta receptors",
author = "Baer, {Hans U.} and Helmut Friess and Mohamed Abou-Shady and Pascal Berberat and Arthur Zimmermann and Gold, {Leslie I.} and Murray Korc and B{\"u}chler, {Markus W.}",
year = "1998",
language = "English (US)",
volume = "10",
pages = "1031--1039",
journal = "European Journal of Gastroenterology and Hepatology",
issn = "0954-691X",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Transforming growth factor betas and their receptors in human liver cirrhosis

AU - Baer, Hans U.

AU - Friess, Helmut

AU - Abou-Shady, Mohamed

AU - Berberat, Pascal

AU - Zimmermann, Arthur

AU - Gold, Leslie I.

AU - Korc, Murray

AU - Büchler, Markus W.

PY - 1998

Y1 - 1998

N2 - Background. Transforming growth factor betas (TGF-βs) are a group of homologous polypeptides that exert pleiotropic effects on various cell types and stimulate the formation of extracellular matrix and fibrosis. To evaluate whether TGF-β isoforms (TGF-β1, TGF-β2 and TGF-β3) and their receptors (types I-III) are also of importance in the pathophysiology of liver cirrhosis, we analysed their concomitant expression and localization in human liver cirrhosis. Patients. Cirrhotic liver tissue samples were obtained from 17 patients (four women, 13 men) with a median age of 41 years (range 22-67). Normal liver tissues from ten patients (seven women, three men) with a median age of 55 years (range 45-75) served as controls. Methods. The tissues were fixed in Bouin's solution and paraffin-embedded for histological analysis. For RNA analysis, freshly obtained tissue samples were snap-frozen in liquid nitrogen and stored at -80°C until analysed. Northern blot analysis was used to examine the expression of TGF-β1, β2 and β3 and their receptors, type I (TβR-I), type II (TβR-II) and type III (TβR-III). Immunohistochemistry was performed to determine the localization of the corresponding proteins in the normal and the cirrhotic liver. Results. Northern blot analysis revealed enhanced expression (P <0.05) of TGF-β1 (twofold increase), TGF-β2 (threefold increase) and TGF-β3 (8.5-fold increase) and of TβR-II (threefold increase) mRNA in liver cirrhosis in comparison with normal controls. In contrast, TβR-I (ALK-5) and TβR-III mRNA expression showed no significant changes. No TGF-β isoform immunoreactivity was present in hepatocytes in either normal livers or in liver cirrhosis. However, in liver cirrhosis, intense TGF-β1 immunoreactivity was present in bile duct and ductular epithelial cells (including ductular proliferations) and in inflammatory cells. In a few sinusoidal lining cells, faint TGF-β1 and moderate TGF-β2 immunoreactivity was present. TGF-β3 immunostaining was present in bile duct and ductular epithelial cells, in inflammatory cells and in fibroblast-like spindle cells in liver cirrhosis. For TβR-I and TβR-II, the immunoreactivity was localized in hepatocytes and biliary cells in normal and cirrhotic liver tissues, with higher intensity for TβR-II in the cirrhotic liver. Conclusion. Enhanced expression of all three TGF-β isoforms and of TβR-II in liver cirrhosis suggests their involvement in this fibrotic disorder. The higher immunoreactivity of the three TGF-β isoforms in the bile duct epithelial cells in cirrhotic tissues suggests a possible role of these cells in the pathogenesis of liver cirrhosis.

AB - Background. Transforming growth factor betas (TGF-βs) are a group of homologous polypeptides that exert pleiotropic effects on various cell types and stimulate the formation of extracellular matrix and fibrosis. To evaluate whether TGF-β isoforms (TGF-β1, TGF-β2 and TGF-β3) and their receptors (types I-III) are also of importance in the pathophysiology of liver cirrhosis, we analysed their concomitant expression and localization in human liver cirrhosis. Patients. Cirrhotic liver tissue samples were obtained from 17 patients (four women, 13 men) with a median age of 41 years (range 22-67). Normal liver tissues from ten patients (seven women, three men) with a median age of 55 years (range 45-75) served as controls. Methods. The tissues were fixed in Bouin's solution and paraffin-embedded for histological analysis. For RNA analysis, freshly obtained tissue samples were snap-frozen in liquid nitrogen and stored at -80°C until analysed. Northern blot analysis was used to examine the expression of TGF-β1, β2 and β3 and their receptors, type I (TβR-I), type II (TβR-II) and type III (TβR-III). Immunohistochemistry was performed to determine the localization of the corresponding proteins in the normal and the cirrhotic liver. Results. Northern blot analysis revealed enhanced expression (P <0.05) of TGF-β1 (twofold increase), TGF-β2 (threefold increase) and TGF-β3 (8.5-fold increase) and of TβR-II (threefold increase) mRNA in liver cirrhosis in comparison with normal controls. In contrast, TβR-I (ALK-5) and TβR-III mRNA expression showed no significant changes. No TGF-β isoform immunoreactivity was present in hepatocytes in either normal livers or in liver cirrhosis. However, in liver cirrhosis, intense TGF-β1 immunoreactivity was present in bile duct and ductular epithelial cells (including ductular proliferations) and in inflammatory cells. In a few sinusoidal lining cells, faint TGF-β1 and moderate TGF-β2 immunoreactivity was present. TGF-β3 immunostaining was present in bile duct and ductular epithelial cells, in inflammatory cells and in fibroblast-like spindle cells in liver cirrhosis. For TβR-I and TβR-II, the immunoreactivity was localized in hepatocytes and biliary cells in normal and cirrhotic liver tissues, with higher intensity for TβR-II in the cirrhotic liver. Conclusion. Enhanced expression of all three TGF-β isoforms and of TβR-II in liver cirrhosis suggests their involvement in this fibrotic disorder. The higher immunoreactivity of the three TGF-β isoforms in the bile duct epithelial cells in cirrhotic tissues suggests a possible role of these cells in the pathogenesis of liver cirrhosis.

KW - Fibrogenesis

KW - Immunohistochemistry

KW - Liver cirrhosis

KW - Northern blot analysis

KW - Transforming growth factor-beta

KW - Transforming growth factor-beta receptors

UR - http://www.scopus.com/inward/record.url?scp=0032436178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032436178&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 1031

EP - 1039

JO - European Journal of Gastroenterology and Hepatology

JF - European Journal of Gastroenterology and Hepatology

SN - 0954-691X

IS - 12

ER -